VITASPRING BIOMEDICAL CO., LTD. (VSBC)

Every figure this model derived for VSBC, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-04-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2023-01-31
cash 8,167 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents 2026-04-30
current assets 9,772 AssetsCurrent 2026-04-30
current liabilities 4,517,844 LiabilitiesCurrent 2026-04-30
equity -4,506,412 StockholdersEquity 2026-04-30
interest expense 163 InterestPaidNet 2026-04-30
ocf 4,182 NetCashProvidedByUsedInOperatingActivities 2026-04-30
revenue 0 Revenues 2026-04-30
sbc 0 ShareBasedCompensation 2026-01-31

The ratios

The figures themselves rather than their scores — what somebody looking up VSBC on one particular measure came for.

RatioValue
current ratio0.0
current ratio reported0.0
dilution pct0.0
growth cv1.09
interest cover-2405.57

What to be careful about

What this model itself distrusts about VSBC's figures. Written by the derivation as it ran, not added afterwards.